1. Home
  2. UGRO vs CNSP Comparison

UGRO vs CNSP Comparison

Compare UGRO & CNSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UGRO
  • CNSP
  • Stock Information
  • Founded
  • UGRO 2014
  • CNSP 2017
  • Country
  • UGRO United States
  • CNSP United States
  • Employees
  • UGRO N/A
  • CNSP N/A
  • Industry
  • UGRO Industrial Specialties
  • CNSP Biotechnology: Pharmaceutical Preparations
  • Sector
  • UGRO Consumer Discretionary
  • CNSP Health Care
  • Exchange
  • UGRO Nasdaq
  • CNSP Nasdaq
  • Market Cap
  • UGRO 8.8M
  • CNSP 6.5M
  • IPO Year
  • UGRO N/A
  • CNSP 2019
  • Fundamental
  • Price
  • UGRO $0.79
  • CNSP $0.09
  • Analyst Decision
  • UGRO Strong Buy
  • CNSP Strong Buy
  • Analyst Count
  • UGRO 2
  • CNSP 1
  • Target Price
  • UGRO $5.63
  • CNSP $0.50
  • AVG Volume (30 Days)
  • UGRO 109.7K
  • CNSP 17.2M
  • Earning Date
  • UGRO 03-26-2025
  • CNSP 03-31-2025
  • Dividend Yield
  • UGRO N/A
  • CNSP N/A
  • EPS Growth
  • UGRO N/A
  • CNSP N/A
  • EPS
  • UGRO N/A
  • CNSP N/A
  • Revenue
  • UGRO $70,320,066.00
  • CNSP N/A
  • Revenue This Year
  • UGRO $17.15
  • CNSP N/A
  • Revenue Next Year
  • UGRO $21.76
  • CNSP N/A
  • P/E Ratio
  • UGRO N/A
  • CNSP N/A
  • Revenue Growth
  • UGRO 12.08
  • CNSP N/A
  • 52 Week Low
  • UGRO $0.60
  • CNSP $0.08
  • 52 Week High
  • UGRO $2.84
  • CNSP $23.90
  • Technical
  • Relative Strength Index (RSI)
  • UGRO 39.50
  • CNSP 37.39
  • Support Level
  • UGRO $0.66
  • CNSP $0.09
  • Resistance Level
  • UGRO $1.02
  • CNSP $0.10
  • Average True Range (ATR)
  • UGRO 0.13
  • CNSP 0.01
  • MACD
  • UGRO 0.01
  • CNSP -0.00
  • Stochastic Oscillator
  • UGRO 36.76
  • CNSP 26.90

About UGRO urban-gro Inc.

Urban-gro Inc is an integrated professional services and construction design-build firm. Its business focuses predominantly on providing fee-based knowledge-based services as well as the value-added reselling of equipment. The company offers value-added architectural, engineering, systems procurement and integration, and construction design-build solutions to customers operating in the controlled environment agriculture (CEA) and industrial and other commercial (Commercial) sectors. It derives revenue predominately from the sale of equipment systems, services, construction design-build, and other various immaterial contracts with customers.

About CNSP CNS Pharmaceuticals Inc.

CNS Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. It is involved in the development of Berubicin, which is a therapy for the treatment of glioblastoma. Glioblastomas are tumors that arise from astrocytes, which are star-shaped cells that make up the supportive tissue of the brain.

Share on Social Networks: